MGI Purchase Of Guilford Will Create Two-Product Acute Care Sales Force

Reps will target surgeons and anesthesiologists to promote Aloxi post-operative nausea treatment and the pipeline sedative Aquavan. The $177.5 mil. merger is expected to close in the fourth quarter.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet